News room - Whats been happening?

From new centres and equipment to the latest in care, stay on top with what we are doing

Mixed-Reality-Viewer-GenesisCare

First UK patients use state-of-the-art Mixed Reality Viewer to visualise and understand their cancer tumour treatment

13 February, 2020

For the first time, patients in the UK will have access to Brainlab Mixed Reality Viewer as part of their cancer treatment; a new way for physicians to provide visualisation of treatment to their patients, actively involving them in their own cancer care. GenesisCare has launched the revolutionary new technology at its Oxford centre for…

Read More

December 2019

13 December, 2019

21st Century Oncology to join Australia’s GenesisCare in a partnership to increase access to high quality cancer care in U.S. communities

FLORIDA, U.S. – Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated cancer treatments, 21st Century Oncology, to become part of Australian cancer and cardiac care company, GenesisCare. The combined experience and reach of 21st Century Oncology’s…

10 December, 2019

GenesisCare UK brings MRIdian radiotherapy to the UK, shortening treatment time for prostate cancer and offering new hope to people with difficult to treat tumours

For the first time, patients in the UK now have access to MRIdian – the world’s smartest radiotherapy treatment – at GenesisCare’s treatment centre in Oxford.  This technology combines magnetic resonance imaging (MRI) techniques with extremely precise radiotherapy beams, enabling the clinician to visualise the exact position and shape of a patient’s tumour in real…


November 2019

13 November, 2019

Latest innovations in prostate cancer treatments in the UK

GenesisCare has recently worked with The Jewish Chronicle to raise awareness of our innovations in prostate cancer treatments in the UK.  Read our article that appeared in their November Health Supplement on Thursday 14th November 2019, where we take about the MRIdian Linac, spacing gels and 177Lutetium PSMA therapy. Prostate cancer is the most common…


October 2019

23 October, 2019

Patients to receive innovative treatments in new state-of-the-art cancer centre

Cancer patients will benefit from a £20 million investment that will see a new state-of-the-art diagnostic and treatment centre built in Surrey. Royal Surrey NHS Foundation Trust is working with specialist oncology group GenesisCare to provide the new facility, which is expected to open in late 2021. Eligible NHS patients and staff will have access…


September 2019

23 September, 2019

‘New hope for advanced prostate cancer patients’

GenesisCare has recently worked with Health Awareness UK and the Guardian on their Urology Health campaign. Read our article that appeared in the Guardian on Monday 23rd September 2019 where Yong Du, Clinical Director, Nuclear Medicine and Theranostics talks about how 177Lutetium PSMA therapy works and it’s benefits to men with late stage prostate cancer…

12 September, 2019

‘It’s time that breast cancer care got personal’

GenesisCare has recently worked with Health Awareness UK and the Guardian on their Breast Health campaign. In the article that appeared in the Guardian on Tuesday 10th September 2019 our Chief Medical Officer Dr Penny Kechagioglou, Simon Smith (Surgical Clinical Director) and Eliot Sims (Clinical Director, Breast Oncology) discuss the importance of early detection, the…


August 2019